Abstract
NOD2/caspase recruitment domain (CARD)15 variants are identified in up to 50% of Crohn's disease (CD) patients. Functional variants of toll-like receptor-4 (TLR4) and CD14 genes may also be relevant to disease pathophysiology. We aimed to assess the contribution of NOD2/CARD15, TLR4 and CD14 variants in Scottish and Irish CD patients. In all, 612 patients with well-characterised inflammatory bowel disease (252 Scottish CD, 247 Scottish UC, 113 Irish CD) and 304 controls were genotyped for variants of NOD2/CARD15 (1007fsinsC, G908R, R702W, P268S), TLR4 (A299G) and CD14 (T-159C). Genotype–phenotype analyses were performed. Variant 1007fsinsC (P=0.003) and G908R (P=0.008) but not R702W (P=0.269) alleles were more prevalent in Scottish CD (4.7, 1.8 and 7.1%, respectively) than Scottish control (2.3, 0.3 and 5.4%). CD allelic frequencies were lower than the series from Europe (P<0.00001) and North America (P<0.00001) but not Scandinavia (P<0.7). Associations were identified with age at diagnosis (P=0.002), ileal disease (P<0.02), penetrating disease (P=0.04) and inflammatory joint disease (P<0.02). TLR4 and CD14 variants did not differ between CD and controls. In conclusion, we present compelling evidence for genetic heterogeneity within Europe. These NOD2/CARD15 variants have a minor contribution in Scottish and Irish CD patients, consistent with an emerging pattern from Northern Europe.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Loftus Jr EV, Sandborn WJ . Epidemiology of inflammatory bowel disease. Gastroenterol Clin N Am 2002; 31: 1–20.
Kyle J . Crohn's disease in the northeastern and northern Isles of Scotland: an epidemiological review. Gastroenterology 1992; 103: 392–399.
Armitage E, Drummond H, Ghosh S, Ferguson A . Incidence of juvenile onset Crohn's disease in Scotland. Lancet 1999; 353: 1496–1497.
Sawczenko A, Sandhu BK, Logan RF et al. Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet 2001; 357: 1093–1094.
Satsangi J, Morecroft J, Shah NB, Nimmo E . Genetics of inflammatory bowel disease: scientific and clinical implications. Best Pract Res Clin Gastroenterol 2003; 17: 3–18.
Ogura Y, Bonen DK, Inohara N et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603–606.
Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599–603.
Abreu MT, Taylor KD, Lin YC et al. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology 2002; 123: 679–688.
Vermeire S, Wild G, Kocher K et al. CARD15 genetic variation in a Quebec population: prevalence, genotype–phenotype relationship, and haplotype structure. Am J Hum Genet 2002; 71: 74–83.
Cuthbert AP, Fisher SA, Mirza MM et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002; 122: 867–874.
Ahmad T, Armuzzi A, Bunce M et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 2002; 122: 854–866.
Lesage S, Zouali H, Cezard JP et al. CARD15/NOD2 mutational analysis and genotype–phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002; 70: 845–857.
Yamazaki K, Takazoe M, Tanaka T, Kazumori T, Nakamura Y . Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease. J Hum Genet 2002; 47: 469–472.
Inoue N, Tamura K, Kinouchi Y et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002; 123: 86–91.
Croucher PJ, Mascheretti S, Hampe J et al. Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations. Eur J Hum Genet 2003; 11: 6–16.
Sugimura K, Taylor KD, Lin YC et al. A novel NOD2/CARD15 haplotype conferring risk for Crohn's disease in Ashkenazi Jews. Am J Hum Genet 2003; 72: 509–518.
Bonen DK, Ogura Y, Nicolae DL et al. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology 2003; 124: 140–146.
Hampe J, Cuthbert A, Croucher PJ et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001; 357: 1925–1928.
Radlmayr M, Torok HP, Martin K, Folwaczny C . The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn's disease. Gastroenterology 2002; 122: 2091–2092.
Murillo L, Crusius JB, van Bodegraven AA, Alizadeh BZ, Pena AS . CARD15 gene and the classification of Crohn's disease. Immunogenetics 2002; 54: 59–61.
Cavanaugh JA, Adams KE, Quak EJ et al. CARD15/NOD2 risk alleles in the development of Crohn's disease in the Australian population. Ann Hum Genet 2003; 67 (Part 1): 35–41.
Helio T, Halme L, Lappalainen M et al. CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease. Gut 2003; 52: 558–562.
Bairead E, Harmon DL, Curtis AM et al. Association of NOD2 with Crohn's disease in a homogenous Irish population. Eur J Hum Genet 2003; 11: 237–244.
Thjodleifsson B, Sigthorsson G, Cariglia N et al. Subclinical intestinal inflammation: an inherited abnormality in Crohn's disease relatives? Gastroenterology 2003; 124: 1728–1737.
Hampe J, Grebe J, Nikolaus S et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. Lancet 2002; 359: 1661–1665.
Zhou Z, Lin XY, Akolkar PN et al. Variation at NOD2/CARD15 in familial and sporadic cases of Crohn's disease in the Ashkenazi Jewish population. Am J Gastroenterol 2002; 97: 3095–3101.
Silverberg MS, Daly MJ, Moskovitz DN et al. Diagnostic misclassification reduces the ability to detect linkage in inflammatory bowel disease genetic studies. Gut 2001; 49: 773–776.
Gasche C, Scholmerich J, Brynskov J et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000; 6: 8–15.
Arnott ID, Satsangi J . Crohn's disease or Crohn's diseases? Gut 2003; 52: 460–461.
Girardin SE, Boneca IG, Viala J et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003; 278: 8869–8872.
Barton GM, Medzhitov R . Toll-like receptor signaling pathways. Science 2003; 300: 1524–1525.
Shimazu R, Akashi S, Ogata H et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 1999; 189: 1777–1782.
Cario E, Podolsky DK . Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 2000; 68: 7010–7017.
Arbour NC, Lorenz E, Schutte BC et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25: 187–191.
Rioux JD, Silverberg MS, Daly MJ et al. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 2000; 66: 1863–1870.
Grimm MC, Pavli P, Van de PE, Doe WF . Evidence for a CD14+ population of monocytes in inflammatory bowel disease mucosa—implications for pathogenesis. Clin Exp Immunol 1995; 100: 291–297.
Rugtveit J, Haraldsen G, Hogasen AK et al. Respiratory burst of intestinal macrophages in inflammatory bowel disease is mainly caused by CD14+L1+ monocyte derived cells. Gut 1995; 37: 367–373.
Hubacek JA, Rothe G, Pit’ha J et al. C(−260)–>T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 1999; 99: 3218–3220.
Klein W, Tromm A, Griga T et al. Interaction of polymorphisms in the CARD15 and CD14 genes in patients with Crohn disease. Scand J Gastroenterol 2003; 38: 834–836.
Klein W, Tromm A, Griga T et al. A polymorphism in the CD14 gene is associated with Crohn disease. Scand J Gastroenterol 2002; 37: 189–191.
Obana N, Takahashi S, Kinouchi Y et al. Ulcerative colitis is associated with a promoter polymorphism of lipopolysaccharide receptor gene, CD14. Scand J Gastroenterol 2002; 37: 699–704.
Capelli C, Redhead N, Abernethy JK et al. A Y chromosome census of the British Isles. Curr Biol 2003; 13: 979–984.
Marsh S, McLeod HL . Crohn's disease: ethnic variation in CARD15 genotypes. Gut 2003; 52: 770.
Esters N, Pierik M, van Steen K et al. Transmission of CARD15 (NOD2) variants within families of patients with inflammatory bowel disease. Am J Gastroenterol 2004; 99: 299–305.
Orchard TR, Dhar A, Simmons JD, Vaughan R, Welsh KI, Jewell DP . MHC class I chain-like gene A (MICA) and its associations with inflammatory bowel disease and peripheral arthropathy. Clin Exp Immunol 2001; 126: 437–440.
Orchard TR, Thiyagaraja S, Welsh KI, Wordsworth BP, Hill Gaston JS, Jewell DP . Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease. Gastroenterology 2000; 118: 274–278.
Giallourakis C, Stoll M, Miller K et al. IBD5 is a general risk factor for inflammatory bowel disease: replication of association with Crohn disease and identification of a novel association with ulcerative colitis. Am J Hum Genet 2003; 73: 205–211.
Lennard-Jones JE . Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989; 170: 2–6.
Miller SA, Dykes DD, Polesky HF . A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
Schlesselman JJ, Stolley PD . Case Control Studies: Design, Conduct, Analysis Hardcover edn. Oxford Press: Oxford, 1982.
Author information
Authors and Affiliations
Corresponding author
Additional information
Conflicts of interest: none
Rights and permissions
About this article
Cite this article
Arnott, I., Nimmo, E., Drummond, H. et al. NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe?. Genes Immun 5, 417–425 (2004). https://doi.org/10.1038/sj.gene.6364111
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gene.6364111
Keywords
This article is cited by
-
Local genetic variation of inflammatory bowel disease in Basque population and its effect in risk prediction
Scientific Reports (2022)
-
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms: New data and a meta-analysis
BMC Gastroenterology (2014)
-
Positive link between variant Toll-like receptor 4 (Asp299Gly and Thr399Ile) and colorectal cancer patients with advanced stage and lymph node metastasis
Tumor Biology (2014)
-
Confirmation of three inflammatory bowel disease susceptibility loci in a Chinese cohort
International Journal of Colorectal Disease (2012)
-
Haplotype in the IBD5 region is associated with refractory Crohn’s disease in Slovenian patients and modulates expression of the SLC22A5 gene
Journal of Gastroenterology (2011)